The Petri Dish: Biogen secures $1.5B loan; Mersana CEO departs after trial failure


Biogen is acquiring Reata Pharmaceuticals with the help of a hefty loan, Novo Nordisk teams up with the Broad Institute and other life sciences news you may have missed.

Previous Lilly backs Watertown cancer startup in $175M round
Next Phoenix City Council approves 1,890 more apartment units in midtown